SEC 13F Intelligence

Worth Venture Partners, LLC / GRTX

Worth Venture Partners, LLC’s Galera Therapeutics Equiclass Equity Position

Does Worth Venture Partners, LLC own Galera Therapeutics Equiclass Equity (GRTX)? Not currently — the last reported position was 472.2K shares worth $4M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q3 2021
Shares
472.2K
% of Portfolio
+1.72%
Quarters Held
3
position exited

Position History GRTX

Reported value by quarter
Q1 ’21: $2MQ1 ’21Q2 ’21: $5MQ2 ’21Q3 ’21: $4MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021472.2K$4M+1.72%
Q2 2021469.2K$5M+1.72%
Q1 2021214.2K$2M+0.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Worth Venture Partners, LLC’s full portfolio or all institutional holders of GRTX.